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In a malaria-endemic area of Africa, rabies was an
important cause of fatal central nervous system infection,
responsible for 14 (10.5%) of 133 cases. Four patients had
unusual clinical manifestations, and rabies was only diag-
nosed postmortem. Three (11.5%) of 26 fatal cases origi-
nally attributed to cerebral malaria were due to rabies.
R
abies is a viral infection of the nervous system, caused
principally by rabies virus (genus Lyssavirus, family
Rhabdoviridae) and occasionally by other related enzootic
viruses (1,2). After a brief nonspecific febrile prodrome,
patients usually manifest either furious (hydrophobic) or
paralytic rabies (3). The incidence of rabies in many parts
of Africa is unknown, but rabies is probably underdiag-
nosed.
Cerebral malaria is a common cause of death in
African children. It is diagnosed clinically in comatose
patients with acute Plasmodium falciparum infection and
no other apparent cause of reduced consciousness (4).
However, asymptomatic P. falciparum infection is com-
mon, and other infections must be excluded before coma is
attributed to the parasites alone. As part of a prospective
clinical study of viral central nervous system (CNS) infec-
tions and cerebral malaria in Malawian children, we inves-
tigated fatal cases for rabies virus.
The Study
At the Queen Elizabeth Central Hospital, Blantyre,
Malawi (an area hyperendemic for P. falciparum malaria),
for 3 years beginning March 2002, we enrolled children (2
months to 15 years) with suspected CNS infection into a
study. Suspected CNS infection was defined as a fever or
history of fever and at least 1 of the following (5): reduced
level of consciousness (Blantyre coma score [BCS] <4 [6]
or for children >10 years of age, Glasgow coma score
<14); neck stiffness; photophobia; Kernig sign; tense
fontanelle; focal neurologic signs; convulsions. Children
were excluded if they had a simple febrile convulsion (7)
or acute bacterial meningitis (cerebrospinal fluid [CSF]
leukocyte count >1,000 cells/µL or a positive Gram stain
or bacterial culture).
A full history was obtained and detailed examination
performed on admission and at least twice daily until dis-
charge or death. Blood was taken for hematocrit determi-
nation, examination for asexual forms of P. falciparum,
full blood count, blood cultures, biochemical screen, and
viral serologic tests. On admission, a lumbar puncture was
performed, and CSF was taken for cell count; differential
cell count; protein and glucose concentrations; Gram stain;
bacterial culture; viral PCR; and viral culture.
Patients with hydrophobia (defined as phobic general-
ized spasms and inspiratory spasms against a closed glot-
tis in response to the offer of a glass of water) or
aerophobia (a similar response to blowing air across the
cheek) were defined clinically as having rabies encephali-
tis. Children with a CSF count of 5–1,000 leukocytes/µL
or features of septicemia were treated with broad-spectrum
antimicrobial agents. Children with malaria parasitemia
were treated with parenteral quinine. For fatal cases, per-
mission was sought for autopsy or supraorbital needle
biopsy. Samples of human brain tissue were analyzed for
rabies virus by using the fluorescent antibody test (8), the
rabies tissue culture inoculation test, and the mouse inocu-
lation test (9). We used reverse transcriptase–PCR to pro-
duce sequence data for phylogenetic analysis (10). The
study was approved by ethics committees in Blantyre and
Liverpool, and signed informed consent was obtained from
patients’ relatives.
During the 3 years, 1,183 children with suspected
CNS infections were assessed; 394 with bacterial meningi-
tis or simple febrile convulsions were excluded, which left
789 children in our study. Rabies encephalitis was diag-
nosed in 10 children (1.3%) on the basis of history of expo-
sure to a rabid animal and initial clinical manifestations
(Table). These included 2 children with P. falciparum par-
asitemia. Atotal of 779 children had no clinical features of
furious rabies at the time of admission; 487 of these chil-
dren had malaria parasitemia, including 341 with a BCS
<2/5 who met the case definition of cerebral malaria. In
total, 133 (16.9%) of 789 children died, including 58
(17%) of those with a diagnosis of cerebral malaria and all
10 children who had clinical features of rabies. Consent to
perform autopsies or postmortem examination of needle-
aspirate samples was requested from the relatives of 82 of
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requested) gave consent; 23 for autopsy and 6 for needle
samples. This number included 26 children with a diagno-
sis of cerebral malaria, 2 with a clinical diagnosis of rabies,
and 1 with suspected meningitis. Six of these 29 patients
who died were positive for rabies virus, including the 2
with typical rabies manifestations (patients 9 and 10), 1
diagnosed with meningitis (patient 12), and 3 who had had
a diagnosis of cerebral malaria (patients 5, 6, and 11).
Thus, overall 14 (10.5%) of the 133 fatal cases were
rabies: 10 diagnosed clinically and 4 that were not diag-
nosed until postmortem material was studied virologically.
Three (11.5%) of 26 patients who died with a diagnosis of
cerebral malaria and for whom postmortem material was
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initial clinical manifestations of these 3 children were
indistinguishable from those of children with cerebral
malaria, histologic examination showed that none of these
3 patients had sequestration of parasitized erythrocytes in
cerebral tissue (the pathologic hallmark of cerebral malar-
ia). None of these children, nor the 1 with a diagnosis of
meningitis, had hydrophobia or aerophobia, which are
characteristic of furious rabies; nor did they have limb pain
or paresthesia, which are often reported. The disease pro-
gression did have unusual features, however. Patient 6
became comatose, flaccid, and areflexic. Patient 11 had
periodic episodes of limb shaking; an electroencephalo-
gram during these events showed generalized slow waves
but no seizure activity. Patient 12 behaved oddly when a
bag of intravenous fluid was set up, but he was not
hydrophobic and readily drank water. None of these 4 chil-
dren had an obvious history of exposure to a rabid animal,
although detailed questioning after admission showed pos-
sible exposures (Table).
To determine whether the virus isolates in our study
were genotype 1 rabies virus, representative of viruses cir-
culating locally, or from other lyssavirus genotypes that
also circulate in Africa (e.g., Lagos bat virus genotype 2 or
Duvenhage virus genotype 4), we performed a phylogenet-
ic analysis. This analysis included our clinical isolates,
rabies viruses we isolated from rabid animals during the
course of the study, and other representative strains. We
generated consensus trees and bootstrap values as
described previously (12) and visualized phylogenetic
trees with Treeview version 3.2 (Figure). This analysis
showed that all of our clinical isolates were African geno-
type 1 rabies viruses and were closely related to a virus
isolated from a rabid dog during the study.
Conclusions
This study showed that rabies encephalitis is an
important cause of death among children in Malawi.
Overall 14 (10.5%) of 133 children who died from sus-
pected CNS infections had rabies. For 10 of these children
with hydrophobia, aerophobia, or both, rabies was diag-
nosed clinically (2 of the cases were also confirmed viro-
logically), but rabies in 4 children with no hydrophobia or
aerophobia was not diagnosed until brain material was
examined. In 3 of these 4 children, cerebral malaria had
been diagnosed. Hypotonia and areflexia developed in 2
children, which might have been a clue that rabies was
involved, but these conditions have also been reported in
cerebral malaria (14). Whether coinfection with malaria
parasites might have affected the initial clinical manifesta-
tions of rabies is not certain. Overall ≈11% of deaths ini-
tially attributed to cerebral malaria were actually due to
rabies virus.
Ours was a hospital-based study. The number of rabies
cases in the community is likely to be much higher. In
some parts of Africa, up to 100 rabies cases are estimated
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Figure. Phylogenetic tree, based on 400
nucleotides of the nucleoprotein gene (10),
showing the relationship between rabies
virus isolates in this study from humans (in
boldface) and animals (underlined), and
other representative isolates; GenBank
accession nos. are in parentheses.
Bootstrap values >70% are considered sig-
nificant and are included within the figure.
The Africa 1, 2, 3, and 4 genotypes are
within rabies virus genotype 1 (13). For a
larger representation of this image, see
www.cdc.gov/ncidod/EID/13/1/136-G.htmto occur for each 1 officially reported (15). Although rabies
is a notifiable disease in Malawi, national reporting is hin-
dered by difficulties with the system and the lack of diag-
nostic facilities. Rabies is preventable by treatment with
rabies vaccine after exposure to the virus, and in Malawi
several hundred to several thousand people are treated
annually with purified chick embryo vaccine. However, in
many areas the vaccine is not available, and it was not
given to any of our patients, even though several did seek
treatment after a dog bite.
In summary, rabies is an important cause of death in
children in Malawi, including some for whom cerebral
malaria had been diagnosed. Although these patients had
unusual disease progression for cerebral malaria, only by
examining postmortem material was the diagnosis of
rabies made. Rabies virus should be included in the list of
pathogens to consider before diagnosing cerebral malaria,
especially in fatal cases with hypotonia and areflexia.
Attempts should be made to get tissue for diagnosis, e.g.,
a nuchal skin biopsy, saliva, or CSF antemortem, or a brain
sample postmortem.
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